Browse result page of AntiTbPdb
The total number entries retrieved from this search are 434
ID | Name | Sequence | N-Terminal Modification | C-Terminal Modification | Chemical Modification | Linear/Cyclic | Length | Chirality | Nature | Source | Origin | Species | Strain | Inhibition Concentration | In vitro/ In vivo | Cell Line | Intracellular Inhibition | Cytotoxicity | Animal Model | Effective Dose in model organism | Immune Responce | Mechanism of Action | Target | Combination Therapy | Other Activities | Year of Publication | Pubmed ID/ Patent No. |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
antitb_1403 | LL-37 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | Free | Free | None | Linear | 38 | L | Cationic | Natural | Murine macrophages | Mycobacterium tuberculosis | Mycobacterium tuberculosis H37Rv | MIC = 25μg/ml (24 hours incubation) | in vitro | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | 2011 | 21790937 |
antitb_1404 | LL-37 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | Free | Free | None | Linear | 38 | L | Cationic | Natural | Murine macrophages | Mycobacterium tuberculosis | Mycobacterium tuberculosis H37Rv | MIC = 100 μg/mL (72 hours incubation) | in vitro | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | 2011 | 21790937 |
antitb_1477 | Nocathiacins | not available | NA | NA | NA | Branched cyclic | 0 | NA | Cationic | Natural | Derived from Nocardia species | Mycobacterium pneumoniae | Mycobacterium pneumoniae | MIC = ≤0.008 mg/ml | in vitro | McCoy cell lines | NA | 0.25 μg/ml | NA | NA | NA | Bind to the 23S rRNA of the 50S ribosomal subunit and inhibit translation | 23srRNA subunit of bacteria | NA | NA | 2015 | 25681127 |
antitb_1478 | Lariatin A | GSQLVYRWVGHSNVIKGP | NA | NA | Alpha carbon of glutamine form amide bond with first glycine and gamma carbon of glutamine involved in side chain formation | Cyclic | 18 | D | Cationic | Natural | Derived from Rhodococcusjostii K01â€B0171 | Mycobacterium tuberculosis | Mycobacterium tuberculosis Rv | MIC = 0.39 mg/L | in vitro | NA | NA | NA | NA | NA | NA | Inhibit cell wall biosynthesis | NA | NA | NA | 2015 | 25681127 |
antitb_1479 | Dihydromycoplanecin A (DHMP A) | not available | NA | NA | NA | Branched cyclic | 0 | D | Cationic | Natural | Derived from Actinoplanesawajinensis | Mycobacterium tuberculosis | Mycobacterium tuberculosis Rv | IC50= 0.0125-25mg/ml | in vitro | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | 2015 | 25681127 |
antitb_1480 | Dihydromycoplanecin A (DHMP A) | not available | NA | NA | NA | Branched cyclic | 0 | D | Cationic | Natural | Derived from Actinoplanesawajinensis | Mycobacterium tuberculosis | Mycobacterium tuberculosis Rv | IC90= 0.05 μg/mL | in vitro | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | 2015 | 25681127 |
antitb_1481 | Dihydromycoplanecin A (DHMP A) | not available | NA | NA | NA | Branched cyclic | 0 | D | Cationic | Natural | Derived from Actinoplanesawajinensis | Mycobacterium intracellulare | Mycobacterium intracellulare | IC50= 1.56 μg/ml | in vitro | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | 2015 | 25681127 |
antitb_1482 | Dihydromycoplanecin A (DHMP A) | not available | NA | NA | NA | Branched cyclic | 0 | D | Cationic | Natural | Derived from Actinoplanesawajinensis | Mycobacterium intracellulare | Mycobacterium intracellulare | IC90= 25 μg/mL | in vitro | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | 2015 | 25681127 |
antitb_1483 | Dihydromycoplanecin A (DHMP A) | not available | NA | NA | NA | Branched cyclic | 0 | D | Cationic | Natural | Derived from Actinoplanesawajinensis | Mycobacteria kansaii | Mycobacteria kansaii | IC50= 0.39 μg/mL | in vitro | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | 2015 | 25681127 |
antitb_1484 | Dihydromycoplanecin A (DHMP A) | not available | NA | NA | NA | Branched cyclic | 0 | D | Cationic | Natural | Derived from Actinoplanesawajinensis | Mycobacteria kansaii | Mycobacteria kansaii | IC90= 0.78 μg/mL | in vitro | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | 2015 | 25681127 |
antitb_1485 | Dihydromycoplanecin A (DHMP A) | not available | NA | NA | NA | Branched cyclic | 0 | D | Cationic | Natural | Derived from Actinoplanesawajinensis | Mycobacteria smegmatis | Mycobacteria smegmatis ATCC 607 | MIC = 12.5 μg/mL | in vitro | NA | NA | NA | NA | NA | NA | NA | NA | DHMP A + INH | NA | 2015 | 25681127 |
antitb_1486 | Pitipeptolides A | not available | NA | NA | NA | Branched cyclic | 0 | D | Cationic | Natural | Derived from Cyanobacterium Lyngbya majuscula | Mycobacterium tuberculosis | Mycobacteria smegmatis ATCC 25177 | Reduction in zone of growth to 25 mm at 100 μg conc. | LoVo cancer cells | NA | IC50= 2.25 μg/ml for M.Smegmatis ATCC 25177 | NA | NA | NA | NA | NA | NA | NA | 2015 | 25681127 | |
antitb_1487 | Pitipeptolides A | not available | NA | NA | NA | Branched cyclic | 0 | D | Cationic | Natural | Derived from Cyanobacterium Lyngbya majuscula | Mycobacterium tuberculosis | Mycobacteria smegmatis ATCC 25177 | Reduction in zone of growth to 10 mm at 25 μg | LoVo cancer cells | NA | IC50= 2.25μg/ml for M.Smegmatis ATCC 25177 | NA | NA | NA | NA | NA | NA | NA | 2015 | 25681127 | |
antitb_1488 | Pitipeptolides A | not available | NA | NA | NA | Branched cyclic | 0 | D | Cationic | Natural | Derived from Cyanobacterium Lyngbya majuscula | Mycobacterium tuberculosis | Mycobacteria smegmatis ATCC 35818 | Reduction in zone of growth to 15 mm at 100 μg | LoVo cancer cells | NA | IC50= 1.95 μg/ml for m.Smegmatis ATCC35818 | NA | NA | NA | NA | NA | NA | NA | 2015 | 25681127 | |
antitb_1489 | Pitipeptolides A | not available | NA | NA | NA | Branched cyclic | 0 | D | Cationic | Natural | Derived from Cyanobacterium Lyngbya majuscula | Mycobacterium tuberculosis | Mycobacteria smegmatis ATCC 35818 | Reduction in zone of growth to 9 mm at 25 μg | LoVo cancer cells | NA | IC50= 1.95 μg/ml for m.Smegmatis ATCC35818 | NA | NA | NA | NA | NA | NA | NA | 2015 | 25681127 | |
antitb_1490 | Pitipeptolides A | not available | NA | NA | NA | Branched cyclic | 0 | D | Cationic | Natural | Derived from Cyanobacterium Lyngbya majuscula | Mycobacterium tuberculosis | Mycobacteria smegmatis ATCC 25177 | Reduction in zone of growth to 30 mm at 100 μg | LoVo cancer cells | NA | IC50= 2.25 μg/ml for M.Smegmatis ATCC 25177 | NA | NA | NA | NA | NA | NA | NA | 2015 | 25681127 | |
antitb_1491 | Pitipeptolides A | not available | NA | NA | NA | Branched cyclic | 0 | D | Cationic | Natural | Derived from Cyanobacterium Lyngbya majuscula | Mycobacterium tuberculosis | Mycobacteria smegmatis ATCC 25177 | Reduction in zone of growth to 15 mm at 25 μg | LoVo cancer cells | NA | IC50= 2.25μg/ml for M.Smegmatis ATCC 25177 | NA | NA | NA | NA | NA | NA | NA | 2015 | 25681127 | |
antitb_1492 | Pitipeptolides A | not available | NA | NA | NA | Branched cyclic | 0 | D | Cationic | Natural | Derived from Cyanobacterium Lyngbya majuscula | Mycobacterium tuberculosis | Mycobacteria smegmatis ATCC 35818 | Reduction in zone of growth to 15 mm at 100 μg | LoVo cancer cells | NA | IC50= 1.95 μg/ml for m.Smegmatis ATCC35818 | NA | NA | NA | NA | NA | NA | NA | 2015 | 25681127 | |
antitb_1493 | Pitipeptolides A | not available | NA | NA | NA | Branched cyclic | 0 | D | Cationic | Natural | Derived from Cyanobacterium Lyngbya majuscula | Mycobacterium tuberculosis | Mycobacteria smegmatis ATCC 35818 | Reduction in zone of growth to 10 mm at 25 μg | LoVo cancer cells | NA | IC50= 1.95 μg/ml for m.Smegmatis ATCC35818 | NA | NA | NA | NA | NA | NA | NA | 2015 | 25681127 | |
antitb_1494 | Lacticin 3147 | not available | NA | NA | NA | Branched cyclic | 0 | D | Cationic | Natural | Derived from Lactococcuslactis | Mycobacterium tuberculosis | Mycobacterium tuberculosis H37 Ra | IC90= 7.5 mg/ml (±0.36) | in vitro | NA | NA | NA | NA | NA | NA | Inhibit biosynthesis of peptidoglycan and form pores in bacterial membrane | NA | NA | NA | 2015 | 25681127 |
antitb_1495 | Lacticin 3148 | not available | NA | NA | NA | Branched cyclic | 0 | D | Cationic | Natural | Derived from Lactococcuslactis | Mycobacterium tuberculosis | Mycobacteria kansasii CIT11/06 | IC90= 60 mg/ml (±0.75) | in vitro | NA | NA | NA | NA | NA | NA | Inhibit biosynthesis of peptidoglycan and form pores in bacterial membrane | NA | NA | NA | 2015 | 25681127 |
antitb_1496 | Lacticin 3149 | not available | NA | NA | NA | Branched cyclic | 0 | D | Cationic | Natural | Derived from Lactococcuslactis | Mycobacterium avium | Mycobacterium avium subspecies paratuberculosis ATCC 19698 | IC90= 15mg/ml (±0.30) | in vitro | NA | NA | NA | NA | NA | NA | Inhibit biosynthesis of peptidoglycan and form pores in bacterial membrane | NA | NA | NA | 2015 | 25681127 |
antitb_1497 | Nisin A | not available | NA | NA | NA | Branched cyclic | 0 | D | Cationic | Natural | Derived from Lactococcus lactis | Mycobacterium tuberculosis | Mycobacterium tuberculosis H37 Ra | IC90= >60mg/ml (±0.18) | in vitro | NA | NA | NA | NA | NA | NA | Inhibit biosynthesis of peptidoglycan and form pores in bacterial membrane | NA | NA | NA | 2015 | 25681127 |
antitb_1498 | Nisin A | not available | NA | NA | NA | Branched cyclic | 0 | D | Cationic | Natural | Derived from Lactococcuslactis | Mycobacterium tuberculosis | Mycobacteria kansasii CIT11/06 | IC90= 60 mg/ml (±0.13) | in vitro | NA | NA | NA | NA | NA | NA | Inhibit biosynthesis of peptidoglycan and form pores in bacterial membrane | NA | NA | NA | 2015 | 25681127 |
antitb_1499 | Nisin A | not available | NA | NA | NA | Branched cyclic | 0 | D | Cationic | Natural | Derived from Lactococcuslactis | Mycobacterium avium | Mycobacterium avium subspecies paratuberculosis ATCC 19698 | IC90= >60 mg/ml (± 2.02) | in vitro | NA | NA | NA | NA | NA | NA | Inhibit biosynthesis of peptidoglycan and form pores in bacterial membrane | NA | NA | NA | 2015 | 25681127 |
antitb_1500 | Sansanmycins A (Ssa) | not available | NA | NA | NA | Branched cyclic | 0 | D | Cationic | Natural | Derived from Streptomyces species | Mycobacterium tuberculosis | Mycobacterium tuberculosis H37Rv | IC50= 16 μg/ml | in vitro | NA | NA | NA | NA | NA | NA | Inhibit the MraY translocase present in the bacterial cell membrane | NA | NA | Antibacterial against E.coli, S.aureus, bacillus, pseudomonas | 2015 | 25681127 |
antitb_1501 | Sansanmycins A (Ssa) | not available | NA | NA | NA | Branched cyclic | 0 | D | Cationic | Natural | Derived from Streptomyces species | Mycobacterium tuberculosis | Mycobacterium tuberculosis 2199 | IC50= 32 μg/ml | In vitro | NA | NA | NA | NA | NA | NA | Inhibit the MraY translocase present in the bacterial cell membrane | NA | NA | Antibacterial against E.coli, S.aureus, bacillus, pseudomonas | 2015 | 25681127 |
antitb_1502 | Cyclomarin A | not available | NA | NA | NA | Branched cyclic | 0 | D | Cationic | Natural | Derived from Streptomyces species | Mycobacterium tuberculosis | Mycobacterium tuberculosis H37Rv | IC50= 0.3mg/ml | in vitro | NA | NA | NA | NA | NA | Change the clp1subunit of casinolytic protease by allosteric binding | NA | NA | Antibacterial against E.coli, S.aureus, bacillus, pseudomonas | 2015 | 25681127 | |
antitb_1503 | Massetolide A | not available | NA | NA | NA | Branched cyclic | 0 | D | Cationic | Natural | Derived from Pseudomonas fluorescens SS101 | Mycobacterium tuberculosis | Mycobacterium tuberculosis h37RV | MIC = 5 mg/ml | in vitro | NA | NA | NA | NA | NA | interfere with bacterial cell wall biosynthesis | NA | NA | Antibacterial against E.coli, S.aureus, bacillus, pseudomonas | 2015 | 25681127 | |
antitb_1504 | Visconsin | not available | NA | NA | NA | Branched cyclic | 0 | D | Cationic | Natural | Derived from Pseudomonas species | Mycobacterium tuberculosis | Mycobacterium avium intercellularae | MIC = 10 mg/ml | in vitro | NA | NA | NA | NA | NA | interfere with bacterial cell wall biosynthesis | NA | NA | Antibacterial against E.coli, S.aureus, bacillus, pseudomonas | 2015 | 25681127 | |
antitb_1505 | Bacitracin | not available | NA | NA | NA | Branched cyclic | 0 | D | Cationic | Natural | Derived from Bacillus subtilis | Mycobacterium tuberculosis | Mycobacterium tuberculosis H37Rv | MIC = 130mg/ml | in vitro | NA | NA | NA | NA | NA | NA | inhibit bacterial cell wall synthesis | NA | NA | Antibacterial against E.coli, S.aureus, bacillus, pseudomonas | 2015 | 25681127 |
antitb_1506 | SP508A | R-(zDhb)-PVLALVAAVAATSAAY | R =3-hydroxyldodecanoyl | Free | Dhb= Dihydrobutyric acid | Linear | 18 | L | Cationic | Natural | Derived from Pseudomonas syringae | Mycobacterium smegmatis | Mycobacterium smegmatis ATCC14468 | MIC = 31.25 μg/ml | in vitro | NA | NA | NA | NA | NA | NA | Specific interaction with membrane | NA | NA | Antibacterial against E.coli, S.aureus, bacillus, pseudomonas | 2015 | 25681127 |
antitb_1507 | SP508B | R-(zDhb)-PVLALVAAVAATSAAY | R =3-hydroxyldodecanoyl | Free | Dhb= Dihydrobutyric acid, o-C=o linkage between 12 and 16 amino acid residue | Cyclic | 18 | D | Cationic | Natural | Derived from Pseudomonas syringae | Mycobacterium smegmatis | Mycobacterium smegmatis ATCC14468 | MIC = 62.5 μg/ml | in vitro | NA | NA | NA | NA | NA | Specific interaction with membrane | NA | NA | Antibacterial against E.coli, S.aureus, bacillus, pseudomonas | 2015 | 25681127 | |
antitb_1508 | SP22A | R-(zDhb)-PVVAAVVAVAASAAY | R =3-hydroxyldodecanoyl | Free | Dhb= Dihydrobutyric acid | Linear | 18 | L | Cationic | Natural | Derived from Pseudomonas syringae | Mycobacterium smegmatis | Mycobacterium smegmatis ATCC14468 | MIC = 7.8 μg/ml | in vitro | NA | NA | NA | NA | NA | Specific interaction with membrane | NA | NA | Antibacterial against E.coli, S.aureus, bacillus, pseudomonas | 2015 | 25681127 | |
antitb_1509 | SP22B | R-(zDhb)-PVVAAVVAVAASAAY | R =3-hydroxyldodecanoyl | Free | Dhb= Dihydrobutyric acid, o-C=o linkage between 12 and 16 amino acid residue | cyclic | 18 | D | Cationic | Natural | Derived from Pseudomonas syringae | Mycobacterium smegmatis | Mycobacterium smegmatis ATCC14468 | MIC = 31.25 μg/ml | in vitro | NA | NA | NA | NA | NA | Specific interaction with membrane | NA | NA | Antibacterial against E.coli, S.aureus, bacillus, pseudomonas | 2015 | 25681127 | |
antitb_1510 | SP508A | R-(zDhb)-PVLALVAAVAATSAAY | R =3-hydroxyldodecanoyl | Free | Dhb= Dihydrobutyric acid | Linear | 18 | L | Cationic | Natural | Derived from Pseudomonas syringae | Mycobacterium smegmatis | Mycobacterium smegmatis ATCC14468 | Reduction in zone to15 mm at 31.25 mg/L | in vitro | NA | NA | NA | NA | NA | NA | Specific interaction with membrane | NA | NA | Antibacterial against E.coli, S.aureus, bacillus, pseudomonas | 2015 | 25681127 |
antitb_1511 | SP508B | R-(zDhb)-PVLALVAAVAATSAAY | R =3-hydroxyldodecanoyl | Free | Dhb= Dihydrobutyric acid, o-C=o linkage between 12 and 16 amino acid residue | Cyclic | 18 | D | Cationic | Natural | Derived from Pseudomonas syringae | Mycobacterium smegmatis | Mycobacterium smegmatis ATCC14468 | Reduction in zone to 18 mm at 62.5 mg/L | in vitro | NA | NA | NA | NA | NA | Specific interaction with membrane | NA | NA | Antibacterial against E.coli, S.aureus, bacillus, pseudomonas | 2015 | 25681127 | |
antitb_1512 | SP22A | R-(zDhb)-PVVAAVVAVAASAAY | R =3-hydroxyldodecanoyl | Free | Dhb= Dihydrobutyric acid | Linear | 18 | L | Cationic | Natural | Derived from Pseudomonas syringae | Mycobacterium smegmatis | Mycobacterium smegmatis ATCC14468 | Reduction in zone to 12 mm 7.8 mg/L | in vitro | NA | NA | NA | NA | NA | Specific interaction with membrane | NA | NA | Antibacterial against E.coli, S.aureus, bacillus, pseudomonas | 2015 | 25681127 | |
antitb_1513 | SP22B | R-(zDhb)-PVVAAVVAVAASAAY | R =3-hydroxyldodecanoyl | Free | Dhb= Dihydrobutyric acid, o-C=o linkage between 12 and 16 amino acid residue | cyclic | 18 | D | Cationic | Natural | Derived from Pseudomonas syringae | Mycobacterium smegmatis | Mycobacterium smegmatis ATCC14468 | Reduction in zone to 14 mm at 31.25 mg/L | in vitro | NA | NA | NA | NA | NA | Specific interaction with membrane | NA | NA | Antibacterial against E.coli, S.aureus, bacillus, pseudomonas | 2015 | 25681127 | |
antitb_1514 | Hirsutatins A | not available | Free | Free | None | Branched cyclic | 0 | D | Cationic | Natural | Derived from Hirsutellanivea | Mycobacterium tuberculosis | Mycobacterium tuberculosis H37Rv | MIC =50 mg/ml | in vitro | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | 2015 | 25681127 |
antitb_1515 | Hirsutatins B | not available | Free | Free | None | Branched cyclic | 0 | D | Cationic | Natural | Derived from Hirsutellanivea | Mycobacterium tuberculosis | Mycobacterium tuberculosis H37Rv | MIC = 50 mg/ml | in vitro | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | 2015 | 25681127 |
antitb_1516 | PR-39 | RRRPRPPYLPRPRPPPFFPPRLPPRIPPGFPPRFPPRFP | Free | Free | None | Linear | 39 | L | Cationic | Natural | Derived from pig porcine | Mycobacterium tuberculosis | Mycobacterium tuberculosis H37Rv | Reduction in growth is inhibited to to 30 % at conc. 6.25 mg/L | in vitro | NA | NA | NA | NA | NA | NA | NA | NA | NA | Antibacterial against E.coli, S.aureus, bacillus, pseudomonas | 2015 | 25681127 |
antitb_1517 | PR-39 | RRRPRPPYLPRPRPPPFFPPRLPPRIPPGFPPRFPPRFP | Free | Free | None | Linear | 39 | L | Cationic | Natural | Derived from pig porcine | Mycobacterium tuberculosis | Mycobacterium tuberculosis H37Rv | Reduction in growth is inhibited to to80% at conc. 50 mg/L | in vitro | NA | NA | NA | NA | NA | NA | NA | NA | NA | Antibacterial against E.coli, S.aureus, bacillus, pseudomonas | 2015 | 25681127 |
antitb_1518 | PR-39 | RRRPRPPYLPRPRPPPFFPPRLPPRIPPGFPPRFPPRFP | Free | Free | None | Linear | 39 | L | Cationic | Natural | Derived from pig porcine | Mycobacterium tuberculosis | Mycobacterium tuberculosis H37Rv | IC50 = 17± 9 mg/L | in vitro | NA | NA | NA | NA | NA | NA | NA | NA | NA | Antibacterial against E.coli, S.aureus, bacillus, pseudomonas | 2015 | 25681127 |
antitb_1519 | PR-39 | RRRPRPPYLPRPRPPPFFPPRLPPRIPPGFPPRFPPRFP | Free | Free | None | Linear | 39 | L | Cationic | Natural | Derived from pig porcine | Mycobacterium tuberculosis | Mycobacterium tuberculosis E1380/94 (MDR resistant stain) | IC50= 93± 12 mg/L | in vitro | NA | NA | NA | NA | NA | NA | NA | NA | NA | Antibacterial against E.coli, S.aureus, bacillus, pseudomonas | 2015 | 25681127 |
antitb_1520 | PR-39 | RRRPRPPYLPRPRPPPFFPPRLPPRIPPGFPPRFPPRFP | Free | Free | None | Linear | 39 | L | Cationic | Natural | Derived from pig porcine | Mycobacterium smegmatis | Mycobacterium smegmatis susceptible strain | 50 mg/L | in vitro | NA | NA | NA | NA | NA | NA | NA | NA | Antibacterial against E.coli, S.aureus, bacillus, pseudomonas | 2015 | 25681127 | |
antitb_1521 | PR-39 | RRRPRPPYLPRPRPPPFFPPRLPPRIPPGFPPRFPPRFP | Free | Free | None | Linear | 39 | L | Cationic | Natural | Derived from pig porcine | Mycobacterium tuberculosis | Mycobacterium tuberculosis H37Rv | IC50= 50 mg/L | in vitro | NA | NA | NA | NA | NA | NA | NA | NA | Antibacterial against E.coli, S.aureus, bacillus, pseudomonas | 2015 | 25681127 | |
antitb_1522 | PR-39 | RRRPRPPYLPRPRPPPFFPPRLPPRIPPGFPPRFPPRFP | Free | Free | None | Linear | 39 | L | Cationic | Natural | Derived from pig porcine | Mycobacterium tuberculosis | Mycobacterium tuberculosis E1380/94 (MDR resistant stain) | IC50= 50 mg/L | in vitro | NA | NA | NA | NA | NA | NA | NA | NA | Antibacterial against E.coli, S.aureus, bacillus, pseudomonas | 2015 | 25681127 | |
antitb_1523 | PR-39 | RRRPRPPYLPRPRPPPFFPPRLPPRIPPGFPPRFPPRFP | Free | Free | None | Linear | 39 | L | Cationic | Natural | Derived from pig porcine | Mycobacterium avium | Mycobacterium avium susceptible strain | MIC= 50 mg/L | in vitro | NA | NA | NA | NA | NA | NA | NA | NA | Antibacterial against E.coli, S.aureus, bacillus, pseudomonas | 2015 | 25681127 | |
antitb_1535 | Human neutrohil peptide (HNP-1) | DCYCRIPACIAGERRYGTCIYQGRLWAFCC | Free | Free | Disulphide linkage between cys2-cys30, cys4-cys19,cys9-cys29 | Cyclic | 30 | L | Cationic | Natural | Human neutrophil | Mycobacterium tuberculosis | Mycobacterium tuberculosis H37Rv | 2.5 μg/ml | in vitro | NA | NA | No cytotoxicity | NA | NA | Mediate macrophage to induce TNF-α expression | Inhibit lipid biosynthesi | NA | NA | Antibacterial against E.coli, S.aureus, bacillus, pseudomonas | 2015 | 25613372 |